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When labeled nucleosides ([sH]thymidine, bromodeoxyuridine) are adminis-
tered to rodents, a large fraction ofthymocytes are noted to synthesize DNA (1-
6). Extensive cell proliferation may be critical for the production of peripheral
T lymphocytes with an appropriately diverse repertoire of specificities. The
repertoire also appears to be shaped within the thymus. Clones that react with
self MHC (self tolerance) are deleted (7), while clones that respond to antigen
plus self MHC (self MHC restriction) are selected (8, 9).
Little is known about the types ofaccessory cells, particularly thymic accessory
cells, that are required for thymocyte proliferation. Thymic dendritic cells have
been identified in birds (10), mice (11), rats (12, 13), and man (14). We have
been interested in evaluating the effects ofdendritic cells on thymus function in
vitro given the important accessory role ofthis cell type in the growth and stable
binding of MHC-restricted T cells (15, 16). In addition, IL-1 acts as a cofactor
for thymocyte proliferation (17). Recent experiments have shown that the
enhancing effect of IL-1 on peripheral T cell growth is exerted primarily at the
level ofdendritic cells (18).
Here we describe methods for enriching and depleting the trace population
of dendritic cells that is present in suspensions of teased mouse thymi. We use
this information to show that dendritic cells are powerful accessory cells for
thymocyte mitogenesis. IL-I not only enhances dendritic function 3-10-fold; it
also has the unusual property of inducing the formation oftypical dendritic cells
from la- precursors.
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Materials and Methods
Mice.
￿
Both sexes were used at 5-8 wk. C57BL/6 X DBA/2 F1, BALB/c X DBA/2,
and B6.H-2k mice were from Trudeau Institute, Saranac Lake, NY. C X D2 FI mice
were from Shizuota Agricultural Corp., Shizuoka,Japan.
IL-1 and Anti-IL-1.
￿
Murine rIL-la (5 X 106 U/mg) was a gift from Dr. P. LoMedico,
Hoffman-Laroche, Nutley, NJ (19). Human rIL-la (2-5 X 106 U/mg) was provided by
This work was supported by National Institutes of Health grant AI-13013 and by grants from the
Ministry of Education, Science andCultureofJapan.
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Dr. LoMedico and by Dainippon Pharmaceutical, Osaka, Japan (9). The Ig fraction of
anti-human IL-la (20), and a murine mAb to human IL-la/# (unpublished data), were
generously supplied by Drs. R. Newton (DuPont, Glenolden, PA) and Dainippon Co.,
respectively.
Culture Medium.
￿
We used RPMI 1640 supplemented with 5% FCS, 5 x 10-5 M 2-
ME, and 20,ug/ml gentamicin.
Thymocytes.
￿
Thymus suspensions were prepared by teasing with forceps followed by
further disruption on stainless steel sieves in RPMI 1640 medium. Ia' cellswere depleted
by treatment with anti-la mAb (either B21-2, anti-I-A; 14-4-5S anti-I-E; American Type
Culture Collection, Rockville, MD) (21, 22) and rabbit complement (Pel-Freeze Biologi-
cals, Rodgers, AR; Cedarlane Laboratories Ltd., Hornsby, Ontario, Canada). To verify
the depletion of Ia' cells with anti-I-A, we stained with biotin-anti-I-E followed by PE-
avidin (Becton Dickinson & Co., Mountain View, CA); alternatively we used FITC-1321-2
to monitor depletion with anti-I-E and complement (23). To further deplete accessory
cells, including Ia dendritic cell precursors described in Results, thymus suspensions were
passed over nylon wool. 1-2 x 109 cells in 3-4 ml of medium were applied to 3,g nylon-
wool columns at 37°C and eluted 1 h later with medium supplemented with 20 mM
Hepes at pH 7.2 . Treatment with anti-la and complement, or passage over nylon wool,
each removed ^"25% of total thymocytes.
Accessory Cells.
￿
Splenic dendritic cells were enriched from low-density spleen adherent
fractions (24). Macrophages were resident peritoneal cells selected by adherence to plastic
for 6 h. Thymic dendritic cells accounted for 0 .1% of the cells from manually teased
thymi (Results). To enrich for these cells, suspensions were separated into low- and high-
density fractions on dense Percoll columns. 15-25 x 107 thymus cells were suspended in
1 .5 ml medium and applied to 5 ml of 58.5% isotonic Percoll (Pharmacia Fine Chemicals,
Piscataway, NJ; 6.5 parts isoperc, 1 part FCS, and 2.5 parts PBS). The low-density fraction
contained 40-50% of the thymocytes and all of the dendritic cells, but was depleted of
red and dead cells. Most thymocytes were depleted with mAb GK 1 .5 anti-CD4 (25) and
HO 2.2 anti-CD8 (26) (American Type Culture Collection), and most B cells with rabbit
anti-mouse Ig and complement. Dendritic cell frequencies were determined with FITC-
B21-2 anti-la mAb followed by flow cytometry or microscopy (1 ug/ml; Fig. 3). These
Ia+,Ig cells were consideredto be dendritic cells because most were Fc receptor-negative
and 33D1 antigen-positive, and because macrophages were lacking using staining with
mAb to M1/70 and F4/80 antigens (27).
Mitogenesis Assays.
￿
3 x 105 thymocytes were cultured in 0.2 ml medium in 6-mm flat-
bottomed microtest wells with graded doses of accessory cells and Con A (1 Ag/ml; Sigma
Chemical Co., St. Louis, MO, or Pharmacia Fine Chemicals). Mitogenesis was measured
at 48-60 h by adding [sH]TdR at I juCi/well in 50 ul medium. All data are means of
triplicates in which the standard deviations were <10% of the mean. In some experiments,
we tested the stimulating activity of thymic dendritic cells for allogeneic peripheral T
lymphocytes. The culture conditions were the same as above, except that the T cells were
nylon wool-nonadherent, Ia spleen and proliferation was measured at 96-108 h.
Results
Accessory Cell Dependence of Thymocyte Mitogenesis to Con A and IL-1.
￿
Murine
thymus suspensions reliably showed some proliferative activity when challenged
with 1 ug/ml Con A in culture, and this proliferation was enhanced by exogenous
murine or human IL-la. The fact that thymocytes responded to Con A implied
that some endogenous accessory cells were present. A combination of two
methods was required to prepare thymocytes that were unresponsive to Con A
unless supplemented with exogenous accessory cells: treatment with anti-Ia and
complement, and passage over nylon wool (left hand column of data in Table I).
Graded doses of dendritic cells progressively enhanced the thymocyte re-
sponses to lectin, and lectin plus IL-1 (Table 1, Fig. 1). 0.1-0.3% spleen dendriticTABLE I
Accessory Cell Requirementsfor Thymocyte Mitogenesis to IL-1
INABA ET AL.
￿
15 1
Differentpopulations of thymus cells(left column) were stimulated with 1 kg/ml Con A, murine and
human rIL-1a, and graded dosesof dendriticcells. Replicatecultures were stimulated in theabsence
of Con A but the proliferative responses were <1,000 cpm and are not shown. Note that treatment
with anti-Ia and complement, followed by passage over nylon wool, ablates the "background"
mitogenesis response.
cells restored mitogenic activity to that seen in unfractionated thymus. Higher
dendritic doses yielded higher responses. Adherent peritoneal cells, primarily
macrophages, were 30 times less active than dendritic cells in supporting thy-
mocyte proliferation as reported elsewhere (28), but the function of macrophages
was not enhanced by either murine or human IL- Ia (Fig. 1).
Evidence that IL-1 Can Act at the Level of Dendritic Cells.
￿
Splenic dendritic
cells, which were >90% pure (24), were cultured with IL-1, washed, and then
added to thymocytes in the presence or absence of lectin and/or additional IL-
1 . IL-1-pulsed dendritic cells were 3-10-fold more active than untreated den-
dritic cells (Fig. 2, compare A and O) Pretreating the dendritic cells beforehand
with IL-1 was as effective as IL-1 added continuously to the mitogenesis assay
(compare A and "). However, IL-I did not amplify mitogenesis when it was used
to pretreat the responding thymocytes (compare p and O). The amplifying effect
of IL-1 was comparable over a wide dose range (1-50 U/ml).
To pursue the dendritic cell as a site of action of IL-1, we tested the effect of
neutralizing antibodies. Anti-IL-1 totally blocked the amplifying effect of IL-1
when the cytokine was added continuously to the thymocyte assay (Table II,
compare groups 3 and 4), but the antibody did not inhibit the IL-1-independent
response to Con A (compare groups 1 and 2). The amplified function of IL-1-
pretreated dendritic cells (compare groups 1 and 5) was resistant to anti-IL-1
(compare groups 5 and 6). These results indicate that IL-1 is not carried over
into the thymocyte assay when used to pretreat dendritic cells. Instead, cytokine
Responding thymocytes
(3 x 105)
rIL-1a
added (50
U/ml)
Proliferative response to Con A + graded
of dendritic cells
None 300 1,000 3,000
doses
10,000
cpm x 10-°
Unfractionated None 12.5 21 .2 36.2 86.0 121.8
Murine 37.6 49.8 84.2 147.9 174.9
Human 33.8 50.6 77.5 136.5 184.2
la- None 5.8 14.7 38.7 103.9 206.7
Murine 19.7 35.9 100.9 220.2 283.4
Human 19.0 37.4 105.9 204.0 281.0
Nylon nonadherent None 2.6 11 .6 35 .2 121.0 174.7
Murine 7.1 33.6 98.6 222.6 264.9
Human 6.7 32.3 86.2 222.7 269.6
la- nylon nonadherent None 0.4 4.1 15.0 53.9 107.6
Murine 0.7 12.6 39.7 109.2 147.1
Human 0.7 11 .1 45 .4 128.6 166.0152
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FIGURE 1.
￿
Efficacy of dendriticcellsand macrophages in thymocyteresponsesto Con Aand
Con Aplus IL-1 . Nylon wool-nonadherent, la- thymocytes were challenged with Con A, IL-
I, and graded dosesofaccessory cellsas indicated. Note that dendriticcellsare 30 timesmore
potent than macrophages (compare circles and triangles), and that their function can be
enhanced by exogenous rIL-la (here human IL-I at 50 U/ml; compare open and closed
symbols).
alters the dendritic cell so that it is a better accessory cell for thymocyte
mitogenesis.
Identification and Function ofDendritic Cells in Thymocyte Suspensions.
￿
In mouse
spleen, many dendritic cells and macrophages adhered to plastic, but in manually
disrupted thymi, few adherent cells were evident as reported (29). Thymus
suspensions did contain nonadherent Ia+ small lymphocytes, as detected by
immunofluorescence with FITC-anti-I-A. Most of these cells were Ig'. When B
cells were removed with anti-Ig and complement, Ia+,Ig cells remained that
were larger and more irregular in shape than small lymphocytes. The Ia+,Ig
cells accounted for 0.1-0.3% ofthymus suspensions and were enriched in a low-
density subpopulation that was depleted of most T cells with mAb to CD4 and
CD8. The double-negative Ig populations accounted for ^-2% of thymus sus-
pensions and contained 2-10% Ia' cells. 60-70% ofthe Ia+ cells were killed by
33D1 anti-dendritic cell mAb and complement and >90% by anti-la; none wereE
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￿
Pulsing dendritic cellswith IL-1 amplifies theiraccessory function for thymocyte
mitogenesis. Enriched populations of splenic dendritic cells, or nylon wool-nonadherent Iá
thymocytes, were pretreated for 16 h with or without 50 U/ml rIL-la (see symbols). The
dendritic cells andthymocytes were washed and cultured together with or without additional
IL-1 . 1 ug/ml Con A was present in some cultures (-)but notothers (----). Note that II-
I does not amplify theresponse when used to pretreat thymocytes, but does amplifydendritic
cell function to the same extent as continuous IL-1 .
killed by anti-Ig or anti-Thy-1 (Fig. 3, top). The Ia+ cells had the same irregular
shape and size as splenic dendritic cells (Fig. 3, bottom). The dendritic cell-
enriched preparations lacked cells that could bind antibody-coated red cells or
be stained with Mac-1 mAb (macrophages).
Irradiated, partially enriched thymic dendritic cells supported thymocyte mi-
togenesis to Con A, and to Con A plus IL-1 (Fig. 4), and also stimulated the
MLR (not shown). The accessory function was 50-fold greater than unfraction-
ated thymus (not shown). >90% of the accessory activity was removed by
treatment with anti-la and complement (Fig. 4), and 60-70% with anti-dendritic
cell mAb (not shown). We conclude that thymus contains very small numbers of
dendritic cells. These are enriched in double-negative fractions and are active
accessory cells for the mitogenesis of mature T cells and thymocytes.
IL-1 Induces the Production ofDendritic Cellsfrom la - Precursors.
￿
Low-density,
CD4-, CD8-, Ig thymus cells were cultured 1-2 d with 50 U/ml rIL-1, washed,
and used as accessory cells. As a control, double-negative populations were
depleted ofdendritic cells with anti-la and complement and cultured with IL-1 .
The latter, Ia-, control cultures initially lacked dendritic cells (Fig. 3) but154
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TABLE II
Effect ofAnti-IL-1 on Thymocyte Mitogenesis
Thymus suspensions were depleted of endogenous accessory cells by passage over nylon wool and
treatment with anti-la and complement. Splenic dendritic cells were added to the thymocytes in
graded doses. The dendritic cells were cultured overnight with or without IL-1 and washed before
being added to the thymocyte assay. The assays were supplemented with additional rIL-1 (50 U/ml)
or anti-IL-1 (5 Ag/ml) as indicated. Alldata are shown for responses in the presence of 1'+g/ml Con
A. Note that pretreatment of dendritic cells with IL-I enhanced function 10-fold (group 1 vs. 5),
and that anti-IL-1 blocked the effect of exogenous IL-1 in the thymocyte assay (group 3 vs. 4) but
did not block the function of dendritic cellsthat were pulsed with IL-1 (groups 5-8).
regenerated them in the presence ofIL-1. The new la' population had the same
phenotype as fresh thymic dendritic cells (data not shown, but identical to Fig.
3). Two-thirds ofthe Ia+ cells were sensitive to lysis with anti-dendritic cell mAb
but not with anti-Ig or anti-Thy-1 antibody and complement. The development
ofla' dendritic cells from Ia- cultures was accompanied by the development of
significant stimulating activity in the MLR (Fig. 5, left). The stimulators were
primarily la'; 33D1+, and Fc receptor-negative (Fig. 5, right).
In other experiments (not shown), we notedthat the induction ofIa+ dendritic
cells by IL-1 required 2 d and occurred only in the thymic low-density, double-
negative fraction. Dendritic cells did not develop from high-density fractions, or
from bone marrow suspensions. We were unable to detect la- dendritic cell
precursors in spleen and lymph node. In these organs, double-negative, la
fractions represented <I% of total cells and were primarily macrophages. Pre-
treatment with 900 rads of 's7Cs did not block the development of thymic
dendritic cells from la- precursors. Other recombinant cytokines (IL-2, IL-3,
and GM-CSF) induced few and sometimes no dendritic cells from la- cultures.
We conclude that thymus has a trace group of la- precursors that give rise to
typical Ia' dendritic cells upon culture in IL-1.
IL-1 Enhances the Function of Thymic DC in ThymocyteMitogenesis.
￿
Low-density,
double negative, la- or Ig thymus cultures were maintained for 1-3 d with or
without human or mouse rIL-1. The populations were washed and added in
graded doses to thymocyte mitogenesis assays . Pretreatment with IL-1 enhanced
the accessory function of the double-negative, Ig cultures 10-fold (Table III,
compare groups Aand B). Populations that had been depleted ofdendritic cells
Group
Pretreatment of
spleen dendritic
cells
Addition to thy-
mocyte assay:
rIL-1 anti-
IL-1
Mitogenesis ([sH]TdR incorporation) to
dendritic cell dosesof:
100 300 1,000 3,000
CPm X 10-1
I None - - 0.6 1.8 6.1 14.2
2 - + 0.6 1.7 5.7 13.3
3 + - 1.3 4.7 13.8 39.4
4 + + 0.5 2.2 6.2 17 .4
5 50 U/ml IL-1 - - 4.0 13.1 26.9 57 .0
6 - + 3.6 11.6 23.8 53.7
7 + - 5.6 17.3 30.7 60.9
8 + + 3.5 12.1 28.6 59.5INABA ET AL,
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FIGURE 4.
￿
Function of dendritic cells in thymocyte mitogenesis. Enriched populations of
splenic dendritic cells (left) were compared with partially enriched populations of thymic
dendriticcells prepared as in Fig. 3 by depleting most Tand B lymphocytes with anti-CD4,8
and Ig antibodies andcomplement (right, open symbols). Aliquots of the latter were also treated
with anti-Ia and complement (right, closed symbols) to deplete dendritic cells (see Fig. 3). Each
of the three populations were irradiated and then added to nylon wool-nonadherent, Ia-
thymocytes to test accessory function for mitogenesis to Con A with or without IL-1 . Note
that the function of spleen andthymus accessory cells (open symbols) is enhanced by exogenous
IL-1, and that function is largely ablated by treatment with anti-la and complement (right,
closed symbols).
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FIGURE 5.
￿
IL-1-induced development of MLR stimulating function from la- precursors.
(Left) Low-density, CD4-,CD8- (double-negative or DN), Ig,Ia thymocytes were cultured 2
d with or without 50 U/ml IL-1 . The cultures were washed and used to stimulate allogeneic,
Ia-, nylon-nonadherent spleen T cells. Note that IL-I induces the development of MLR
stimulating function from la- precursors. (Right) Same as left, but the phenotype of the IL-I
induced cultures was studied. Aliquots were either separated into Fc receptor-positive and
-negative fractions by rosetting with antibody-coated red cells (35), or treated with no mAb,
33D1 anti-dendritic cell (33), or anti-la antibody and complement as indicated.Effect ofPreculture with IL-1 on the Accessory Function ofThymic Dendritic Cells
INABA ET AL.
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TABLE III
Thymic dendritic cells (DC) were partially enriched by treating low-density thymocytes with a
combination of anti-CD4, CD8, and Ig antibodies and complement. The cellswere cultured 3 dat 3
X 106 cells/16-mm well with or without 50 U/ml murine rIL-la (groups A and B). Replicates were
treated with anti-Iaand complement (inaddition to theaboveantibodies;groups C andD). The four
types of culture were washed, counted, and added in graded doses to 3 X 105 nylon nonadherent,
la- thymocytes. The mitogenesis assay was performed in thepresence or absence of IL-1 and Con A
as indicated. Note that IL-1 increasesaccessory function about 10-fold (group A vs. B), andinduces
theformation of accessorycells from la- precursors (group C vs. D).
with anti-Ia and complement had no accessory function (group C). However,
when these same cultures were supplemented with IL-1, significant accessory
function developed (group D).
Antibody- and complement-mediated cytolysis was used to verify that the IL-
1-induced accessory cells had the phenotype ofdendritic cells. For both Con A,
and Con A plus IL-1 responses, accessory cell function was reduced by >90%
with anti-la and 60-70% with anti-dendritic cell mAb and complement, but not
by anti-Ig (Fig. 6).
Since our initial experiments revealed significant accessory function in la
thymocytes that was removed by passage over nylon wool (Table I), we tested if
IL-1 would induce dendritic cells from nylon wool-nonadherent fractions. Few
were detected either by immunofluorescence (not shown) or by measurements
of accessory function (Fig. 7). Therefore the nylon wool-adherent fraction of
thymus contains an la- precursor that requires IL-1 to develop the typical
features of lymphoid dendritic cells.
Group Source of
accessorycells
Addition
IL-1
to
thymocyte
assay
Con A
Thymocyte
105
mitogenesis with graded doses
of accessory cells
3 X 10" 10" 3 X 103
cpm X 10-5
Al Enriched thymic DC, cul- - - 0.2 0.2 0.2 0.2
A2 tured without IL-1 + - 0.4 0.3 0.2 0.2
A3 - + 28.7 8.9 3.7 1.4
A4 + + 82.4 26.3 14.1 6.0
B1 Enriched thymic DC, cul- - - 0.8 0.2 0.2 0.2
B2 tured with IL-1 + - 2.2 1.3 0.6 0.4
B3 - + 157.5 55.8 25.0 8.7
B4 + + 231.7 146.0 99.6 33.4
Cl Ia/C*-depleted thymic DC - - 0.3 0.3 0.2 0.2
C2 cultured without IL-1 + - 0.5 0.3 0.3 0.2
C3 - + 0.3 0.3 0.3 0.2
C4 + + 0.7 0.5 0.4 0.3
D1 Ia/C*-depleted thymic DC - - 0.2 0.2 0.2 0.2
D2 cultured with IL-1 + - 1.7 0.7 0.4 0.3
D3 - + 106.1 23.3 8.4 2.6
D4 + + 147.4 53.3 32.0 10.2158
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FIGURE 6.
￿
Phenotype of IL-1-induced accessory cells for thymocyte mitogenesis . Low-den-
sity, double-negative thymocytes were depleted of Ia+ cells as in Figs . 5 and 6 and cultured 3
d in medium with (9) or without (O) 50 U/ml rIL-la . The cells were treated with mAb and
complement, washed, irradiated (900 rad), and tested for accessory function in the thymocyte
mitogenesis response to ConA (left) or to ConA plus IL-1 (right) . Untreated spleen dendritic
cells were used as a positive control (p) . The mAb were none (*), anti-,u (A), 33D1 anti-
dendritic cell (O), and 14-4-5S anti-I-E (O) . Note that IL-1 induces accessory function (compare
0 and (D), and that these accessory cells are sensitive to lysis with anti-la and anti-dendritic
cell, but not anti-Ig and complement . The difference in the efficacy of killing with anti-la
(B21-2) and anti-dendritic cell (33D1) mAb probably reflects the difference in the levels of
the corresponding antigens . Quantitative binding (33) and flow cytometry (not shown) indicate
that the number of B21-2 binding sites is 20-fold higher than 3391 .
FIGURE 7 .
￿
IL-1-dependent, la- dendritic cell precursors are depleted by passage over nylon
wool . Low-density, CD4-,CDS- thymocytes were prepared and depleted of B cells (Ig ; left)
or both B cells and dendritic cells (Ig,Ia- ; right) . Each fraction was then studied with or
without passage over nylon wool, and with or without culture for 3d in medium or in medium
plus IL-i (see legend). If dendritic cells were present initially (left), it is evident that preculture
in IL-1 enhanced accessory function (compare (D and"), and that many of the accessory cells
are initially nylonwool-adherent(compare circles and triangles) . If dendritic cells were depleted
from the starting population (right), accessory function was partially restored by culture in IL-
1 (0) . The IL-1-responsive cells were nylon wool adherent (A) .INABA ET AL.
￿
159
Discussion
These results on thymocyte proliferation to Con A, and to Con A plus IL-1,
represent a beginning for studying the contributions ofdendritic cells to thymus
function in culture. There has been considerable emphasis on the importance of
bone marrow-derived, non-T cells in thymus biology. However the function of
endogenous dendriticcellsin thymocyte responseshas not been explored directly.
The current study shows that two pools of dendritic cells exist in thymus, Ia'
and la-. Both are very active in supporting thymocyte proliferation to Con A,
and IL-1 amplifies their function. Very few macrophages are detected in thymus
suspensions. However, peritoneal macrophages are much less active than den-
dritic cells in responses to lectin, as reported (28). The function ofmacrophages
cannot be enhanced by exogenous IL-1 (Fig. 1).
The difficulty in studying dendritic cells in teased thymic suspensions is that
the frequency is low (0.1-0.3%), and the dendritic cells are nonadherent. We
have been unable to enrich these dendritic cells to a high degree ofpurity (Fig.
3). Nonetheless, the data on partially enriched populations indicate that thymic
and splenic dendritic cells are similar in phenotype and function. In recent
experiments, we have dissociated thymi with collagenase to obtain adherent
dendritic cells and macrophages that are very similar to those found in spleen
(30). The monolayers can be used to prepare highly enriched fractions ofthymic
dendritic cells and macrophages. Adherence-derived dendritic cells behave sim-
ilarly in many respects to the nonadherent dendritic cells described here. In this
study we have focused on manually disrupted thymi, since this is the standard
source ofcells for most studies ofthymocyte function.
Prior work has shown that IL-1 amplifies peripheral T cell mitogenesis by
enhancing dendritic cell function (18). This also seems to be the case for the
thymocyte response to lectin plus IL-1, which is the classical bioassay used to
detect the cytokine (17). When IL-1 is used to pretreat dendritic cells, the
populations can be washed and will exhibit functional activity that is 3-10-fold
enhanced over untreated populations (Figs. 2 and 4; Table III, groups A,B).
The enhanced function resists neutralizing anti-IL-1 antibodies (Table II), indi-
cating that cytokine is not being carried over into the mitogenesisassay. Further
work is needed to test if IL-1 can have additional direct effects on some
thymocytes, but it appears that a major site ofaction of IL-I in lectin responses
is at the level ofdendritic cells.
When IL-1 is used to pretreat la- thymus fractions, the amplifying effect of
cytokine is qualitatively and quantitatively more dramatic (Table III; Figs. 5-7).
No accessory function is seen in the absence of cytokine pretreatment, while
active dendritic cells develop in its presence. Bowers and Berkowicz (31) de-
scribed la- dendritic cell precursors in rat bone marrow maintained in serum
free medium. To date we have not detected a similar population in mouse
marrow.
There is a prior report which may indicate a similar role for IL-1 in intact
thymus to that described here. DeLuca and Mizel (32) reported that anti-I-A
mAb inhibited the recovery of functional T cells from fetal organ cultures.
Exogenous rIL-1 reversed the block. Perhaps IL-1 induced the formation of
needed accessory dendritic cells from la precursors.160
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Summary
The response of thymocytes to lectin is a standard tissue culture model for
identifying cytokines such as IL-1 that are required for thymocyte mitogenesis.
To study accessory cell requirements for these responses, it was necessary to
deplete endogenous accessory cells with two techniques: anti-la and complement,
and passage over nylon wool. Proliferation to Con A wasthen restored with 0.1-
0.3% exogenous splenic dendritic cells, or 30-fold higher levels of peritoneal
macrophages. The "costimulatory" action of IL-1, whereby responses to lectin
were enhanced 3-10-fold, required the presence of dendritic cells. This effect
ofIL-1 could be reproduced by culturing the dendritic cells for 12 h in 1 U/ml
human or murine rIL-1« before addition to the thymocyte proliferation assay.
The function of IL-1-treated dendritic cells was not blocked by a neutralizing
anti-IL-1 antibody.
The endogenous population of thymic accessory cells was partially character-
ized. A trace (0.1-0.3%) fraction of Ia+,Ig, plastic nonadherent dendritic cells
was visualized and enriched to a level of 1-10% by depleting CD4',CD8+, and
Ig+ lymphocytes. When this double-negative population was cultured with IL-1
and washed, the treated thymic dendritic cells were 10-fold more active as
accessory cells. When the CD4-,CD8-,Ig populations were depleted ofdendritic
cells with anti-la and complement, the subsequent addition of IL-1 had a second
effect. la' dendritic cells redeveloped over a 2-d interval, and they exhibited the
same properties as resident dendritic cells in thymus and spleen. The majority
were lysed by 33D1 anti-dendritic cell mAb and complement, lacked Fc recep-
tors, and acted as powerful stimulators ofthe MLR and Con A mitogenesis. The
development of dendritic cells did not occur with IL-2, -3, -4 or granulocyte/
macrophage colony-stimulating factor or in nylon-nonadherent populations. The
IL-1-dependent, la- precursor was not detectable in bone marrow.
These results begin toanalyze the endogenous accessoryfunction ofthethymus
in culture. Dendritic cells actively stimulate thymocyte mitogenesis. The mito-
genic action of IL-1 involves effects on resident la' dendritic cells as well as a
new population of thymic, la- precursors.
We are grateful to P. LoMedico, R. Newton, and Dainippon Pharmaceutical for supplying
the IL-1 reagents used in this paper; and Mary Crowley and Jay Valinsky for the FAGS
studies.
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